Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Vanguard Medica exercises worldwide rights to VML-262

July 19, 1996

Penederm files FDA amendment regarding Avita

July 19, 1996

Taro's clobetasol propionate approved by FDA

July 19, 1996

Stiefel to develop and market CytoMed's CMI-392

July 19, 1996

OncorPharm acquires rights to dithymidine-based products

July 12, 1996

ProCyte seeks FDA marketing clearance for OsmoCyte

July 12, 1996

FDA issues nonapprovable letter for Avita; development elsewhere on track

July 5, 1996

ProCyte launches Iamin gel in U.S.

July 5, 1996

ICN's Viquin Forte launched in U.S.

June 28, 1996

Connective Therapeutics to develop new formulation of betamethasone valerate

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...